Dynamic Contrast Enhancement Computed Tomography Based Technic to Assess Gastro Intestinal Wall Perfusion : Feasibility Study

This feasibility study has therefore several aims:

1. construct a dedicated CT perfusion protocol for GIT wall perfusion; 2. used a two-compartment pharmacokinetic model which is more adapted that a unique compartment model; 3. from the image acquired, evaluate current parameters of perfusion including the permeability ones

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Mesenteric Ischemia Cardiovascular Diseases Digestive System Diseases Gastrointestinal Diseases Intestinal Diseases Peritoneal Diseases Permeability CT Technics Vascular Diseases

Age range

50 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Chu Poitiers

Poitiers, Aquitaine, 86000, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

all patients over fifty years old with clinico-biological suspicion for acute GITischemia admitted at our institution

Exclusion criteria

contra-indication to contrast agent injection as so defined by the European Society of UroRadiology in 2014
inability to provide informed consent

Treatment and study plan

Dynamic contrast enhanced computerised tomography

Radiation

Primary outcomes

number of computerised tomography with interpretable data

Time frame: 2 hours

Sponsors and collaborators

Lead sponsor

Poitiers University Hospital

Other

Registry information

Acronym: PERFE-CT

Important dates

Study start: 2016
Primary completion: 2017
Study completion: 2017
First posted: Dec 8, 2017
Registry last updated: Apr 13, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed